Short interest in TransCode Therapeutics Inc (NASDAQ:RNAZ) increased during the last reporting period, rising from 215.52K to 605.72K. This put 87.01% of the company's publicly available shares short.

Short interest for TransCode Therapeutics gives investors a sense of the degree to which investors are betting on the decline of TransCode Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 506.54K shares traded per day, it would take 1.2 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.